Welcome to the latest edition of our Healthcare & Life Sciences Market Update, in which we explore the evolving landscape of investment trends, regulatory challenges, and strategic opportunities shaping the global market....more
Welcome to the first edition of our European Healthcare & Life Sciences Market Update, a new report summarising key emerging trends, opportunities, and challenges facing the market in 2022. During the last 12 months, the...more
2/10/2022
/ Clinical Trials ,
Digital Health ,
EU ,
EU Clinical Trials Regulation (CTR) ,
Health Care Providers ,
Joint Venture ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Regulatory Agenda ,
Regulatory Standards ,
UK ,
Venture Capital
The healthcare and life sciences (HCLS) sector remained particularly active throughout 2020. Despite the COVID-19 pandemic, deal activity was very strong in the first half of the year — with notable transactions including...more
1/28/2021
/ Acquisitions ,
Compliance ,
Coronavirus/COVID-19 ,
Cross-Border Transactions ,
Cybersecurity ,
Divestment ,
Emerging Markets ,
Health Care Providers ,
Health Technology ,
Healthcare Facilities ,
Hospitals ,
Industry Consolidation ,
Investors ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Physicians ,
Private Equity
Companies should expect an increased focus from activists on certain areas as the COVID-19 economic recovery begins.
The graphic above illustrates the top 10 most popular activists demands from 2015 to date in Germany. In...more